Metrics to compare | OIL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOILPeersSector | |
|---|---|---|---|---|
P/E Ratio | −22.8x | 4.9x | −0.4x | |
PEG Ratio | 0.61 | 0.08 | 0.00 | |
Price/Book | 7.6x | 2.6x | 2.6x | |
Price / LTM Sales | 68.5x | 2.0x | 3.0x | |
Upside (Analyst Target) | - | 92.9% | 50.7% | |
Fair Value Upside | Unlock | 17.4% | 7.2% | Unlock |
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.